RPL15 pseudogene 19 (RPL15P19)

RPL15 pseudogene 19 (RPL15P19) is a processed pseudogene—a non-functional genetic element that arose via retrotransposition of the RPL15 (ribosomal protein L15) gene sequence into another location in the human genome. While the parent gene RPL15 encodes a structural component of the large 60S ribosomal subunit and is essential for protein synthesis and proper ribosome assembly, pseudogenes like RPL15P19 do not code for functional proteins and are not known to participate in biological processes or diseases. Processed pseudogenes, including those derived from ribosomal proteins, are spread throughout the genome and typically lack regulatory elements or coding potential, distinguishing them from protein-coding genes. Thus, RPL15P19 has no recognized function as a protein, receptor, enzyme, or therapeutic target.\n\nRPL15P19 is not a protein-coding gene and does not produce a functional ribosomal protein or any other known molecule; it is a pseudogene derived from the RPL15 parent gene. Ribosomal protein pseudogenes are common and have no known functional biological roles. Pseudogenes, by definition, are not considered therapeutic targets or relevant for pharmacological intervention. RPL15 pseudogene 19 is not a functional gene or target in a therapeutic or biological sense. It should not be conflated with the functional RPL15 gene, which is linked to cancer and anemia. There is nothing therapeutically actionable about this pseudogene, and its inclusion in target or drug-interaction lists would be incorrect. If therapeutic significance is of interest, the correct target is RPL15 (Ribosomal protein L15), not its pseudogenes. RPL15P19 is a genomic pseudogene, not a target for drug discovery, biomarker development, or clinical intervention. If the query refers to the protein-coding gene, the search should focus on "Ribosomal protein L15 (RPL15)" instead.

Other names

RPL15P19